Showing 19,001 - 19,020 results of 46,043 for search '(( 5 ((step decrease) OR (mean decrease)) ) OR ( 50 ((teer decrease) OR (a decrease)) ))', query time: 1.14s Refine Results
  1. 19001
  2. 19002

    Image 3_Evaluation of the cytotoxicity and antibacterial activity of a synthetic tunicamycin derivative against Mycobacterium avium complex.jpeg by Maria A. Colombatti Olivieri (21362615)

    Published 2025
    “…Also, low-dose TunR2 treatment of infected macrophages did not significantly decrease Map survival after 48 h of infection. These results suggest that TunR2 is not a good candidate to treat Map infections.…”
  3. 19003
  4. 19004

    Image 2_Evaluation of the cytotoxicity and antibacterial activity of a synthetic tunicamycin derivative against Mycobacterium avium complex.jpeg by Maria A. Colombatti Olivieri (21362615)

    Published 2025
    “…Also, low-dose TunR2 treatment of infected macrophages did not significantly decrease Map survival after 48 h of infection. These results suggest that TunR2 is not a good candidate to treat Map infections.…”
  5. 19005

    Image 1_Evaluation of the cytotoxicity and antibacterial activity of a synthetic tunicamycin derivative against Mycobacterium avium complex.jpeg by Maria A. Colombatti Olivieri (21362615)

    Published 2025
    “…Also, low-dose TunR2 treatment of infected macrophages did not significantly decrease Map survival after 48 h of infection. These results suggest that TunR2 is not a good candidate to treat Map infections.…”
  6. 19006

    Table 2_Evaluation of the cytotoxicity and antibacterial activity of a synthetic tunicamycin derivative against Mycobacterium avium complex.docx by Maria A. Colombatti Olivieri (21362615)

    Published 2025
    “…Also, low-dose TunR2 treatment of infected macrophages did not significantly decrease Map survival after 48 h of infection. These results suggest that TunR2 is not a good candidate to treat Map infections.…”
  7. 19007

    Table 1_Evaluation of the cytotoxicity and antibacterial activity of a synthetic tunicamycin derivative against Mycobacterium avium complex.docx by Maria A. Colombatti Olivieri (21362615)

    Published 2025
    “…Also, low-dose TunR2 treatment of infected macrophages did not significantly decrease Map survival after 48 h of infection. These results suggest that TunR2 is not a good candidate to treat Map infections.…”
  8. 19008
  9. 19009
  10. 19010
  11. 19011
  12. 19012
  13. 19013

    Gender and T cell responses. by Annemarie Namuniina (16496648)

    Published 2023
    “…The rates of cross-reactive T-cell populations in this exploratory Ugandan population appears higher than previous estimates from resource-rich countries like the United States (20–50% reactivity). It is unclear what role, if any, this cross-reactivity played in decreasing COVID-19 related mortality in Uganda and other African countries, but does suggest that a better understanding of global pre-existing immunological cross-reactivity could be an informative data of epidemiological intelligence moving forward.…”
  14. 19014

    Image_1_Molecular mechanisms regulating natural menopause in the female ovary: a study based on transcriptomic data.jpeg by Quan Liu (486219)

    Published 2023
    “…Increased contents of terminally differentiated HMGB1+ Granulosa and GSTA1+ Granulosa were observed in the ovaries of individuals aged 50-69. Signaling pathway activity analysis indicated a gradual decrease in TGFb and MAPK pathway activity with menopause progression, while p53 pathway activity increased. …”
  15. 19015

    Clade III N-AChR show similar agonist affinities. by Jennifer D. Noonan (14117157)

    Published 2022
    “…<p>Concentration- response curves were measured to determine if declining maximal response is due to decreasing ligand affinity. Concentration-response curves for clade III N-AChRs for (A) acetylcholine and (B) nicotine. …”
  16. 19016

    Rates of hospital admission stratified by gender. by Abdallah Y. Naser (4856113)

    Published 2024
    “…Rates of same-day hospital admission decreased by 13.3% [from 50.55 (95%CI 49.54–51.57) in 1998 to 43.81 (95%CI 43.00–44.63) in 2019 per 100,000 persons]. …”
  17. 19017

    <b>Uncovering the role of the yeast lysine acetyltransferase NuA4 in the regulation of nuclear shape and lipid metabolism</b> by Sarah Laframboise (18338787)

    Published 2024
    “…Disruption of the NuA4 complex results in 70% of cells displaying nuclear deformations and nearly 50% of cells exhibiting vacuolar fragmentation. …”
  18. 19018

    Celecoxib activates SIRT1 in a biochemical, <i>in silico</i> and <i>in vitro</i> cell-based assay. by Madhavi Annamanedi (580922)

    Published 2014
    “…Right - Model showing the interactions of Celecoxib with SIRT1 protein. C. A representative Western blot showing a dose-dependent decrease of Ac-H3K9 levels in presence of celecoxib. * p-value<0.01 compared to Control. …”
  19. 19019

    The formation of a negative image mediated by anti-Hebbian burst time dependent plasticity reduces signal but not noise correlations. by Benjamin Simmonds (682287)

    Published 2015
    “…<p><b>A</b>) One cycle of the 4 Hz sinusoidal stimulus (top, red trace) and synaptic weights (bottom, blue traces) as a function of time for (black traces from top to bottom), t = 0, t = 0.5 sec, t = 1 sec, t = 1.5 sec, t = 2 sec, t = 2.5 sec, t = 3 sec, t = 3.5 sec, t = 4 sec, t = 4.5 sec, t = 5 sec, t = 5.5 sec. …”
  20. 19020

    Data_Sheet_1_Case Report: A Novel Mutation in NFKB1 Associated With Pyoderma Gangrenosum.PDF by Ran Fang (533948)

    Published 2021
    “…The functional analysis showed that the variant caused reduced phosphorylation of p105 and resulted in the decreased processing of p105 to p50. We conclude that the patient's symptoms were caused by dysregulation of the NF-κB signaling pathway.…”